DCDK9-202

CAT: 0804-HY-178861Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-178861Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DCDK9-202 a potent CDK9 PROTAC degrader with an DC50 value of 3.5 nM. dCDK9-202 exhibits broad-spectrum anti-tumor activity and extensively disrupts the oncogenic transcriptome. dCDK9-202 can activate Caspase-3/7, increase the level of cleaved PARP, and directly induce apoptosis of tumor cells. dCDK9-202 effectively inhibits TC-71 tumor growth without any signs of toxicity in mice. dCDK9-202 can be used for the study of EGFR-driven cancers such as sarcoma (Pink: CDK9 ligand (HY-178862) ; Blue: CRBN ligand (HY-W248665) ; Black: Linker (HY-N8015) ) [1].
UNSPSC
12352005
Target
Apoptosis; Caspase; CDK; PARP; PROTACs
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CC(C)(C1=CN=C(O1)CSC2=CN=C(S2)NC(C3CCN(CC3)C(CCCCCCCN4CC5=C(C4)C=C6C(N(C(C6=C5)=O)C7CCC(NC7=O)=O)=O)=O)=O)C
Molecular Formula
C40H49N7O7S2
Molecular Weight
803.99
References & Citations
[1]Ma L, et al. Discovery of dCDK9-202 as a Highly Potent and Selective PROTAC CDK9 Degrader with Strong In Vivo Antitumor Activity. J Med Chem. 2025 Oct 23;68 (20) :21172-21186.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; Caspase 7; CDK9; Cereblon

Related Products

CatalogName
HY-124540ABT-202
HY-115436-01LYG-202
HY-P991437FM-202
HY-P991363-01AX-202
HY-19745-01BMS-202
HY-W287494Antitumor agent-202
HY-101522-01CHMFL-EGFR-202
HY-W1008871CRBN ligand-202
HY-161404Antibacterial agent 202
HY-D1233-01Pigment red 202

Alternative Products

CatalogName
MBS385200-014SC-202
2022/10SR 202
sc-57613Amitriptyline (202)
sc-396595LYG-202
BUP17210-01RGX-202
MF-0020509-01ABT-202
MF-0100817-01FM-202
MBS3602560-01BMS-202
JH919047VANPLAST 202
MBS5781965Kih 202

Popular Products